Cargando…
Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint study
AIMS: Most cases of acute myocardial infarction (MI) in Sweden are treated with long-term β-blocker therapy as secondary prevention. Case studies and patient reports have indicated negative effects of β-blockers including symptoms of depression, fatigue, sexual dysfunction, and general low mood, all...
Autores principales: | Humphries, Sophia, Mars, Katarina, Hofmann, Robin, Held, Claes, Olsson, Erik M G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230287/ https://www.ncbi.nlm.nih.gov/pubmed/37265820 http://dx.doi.org/10.1093/ehjopen/oead036 |
Ejemplares similares
-
Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked study
por: Humphries, Sophia, et al.
Publicado: (2022) -
Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
por: Yndigegn, Troels, et al.
Publicado: (2022) -
When do we need clinical endpoint adjudication in clinical trials?
por: Held, Claes
Publicado: (2019) -
Reducing stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries or Takotsubo syndrome: A non-randomized feasibility study
por: Rondung, Elisabet, et al.
Publicado: (2022) -
The music-related quality of life: Italian validation of MuRQoL into MUSQUAV questionnaire and preliminary data from a cohort of postlingually deafened cochlear implant users
por: Frosolini, A., et al.
Publicado: (2022)